| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.887043 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107171606 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 200507t20202020onc ob f000 0 eng d |
|---|
| 020 | |a9780660349121 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH139-16/2020E-PDF |
|---|
| 245 | 00|aExplanatory notes for drug establishments on the preparation of a site master file. |
|---|
| 246 | 17|aExplanatory notes for drug establishments on the preparation of a site master file (GUI-0005) version 6 |
|---|
| 264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |c2020. |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (15 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Notes explicatives à l'intention des établissements de produits pharmaceutiques sur la préparation d'un dossier d'établissement. |
|---|
| 500 | |a"GUI-0005." |
|---|
| 500 | |a"July 17, 2020." |
|---|
| 500 | |a"Pub.: 200019." |
|---|
| 500 | |aIssued also in HTML format. |
|---|
| 504 | |aIncludes bibliographical references (page 15). |
|---|
| 650 | 0|aPharmaceutical industry|xLicenses|zCanada. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 775 | 08|tNotes explicatives à l'intention des établissements de produits pharmaceutiques sur la préparation d'un dossier d'établissement.|w(CaOODSP)9.887047 |
|---|
| 856 | 40|qPDF|s1.10 MB|uhttps://publications.gc.ca/collections/collection_2020/sc-hc/H139-16-2020-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/directives-guidance-documents-policies/annex-1-explanatory-notes-industry-preparation-site-master/document.html |
|---|